Cargando…

Therapy of autoimmune bullous diseases

Autoimmune bullous diseases result from an immune response to molecular components of the desmosome or basement membrane. Bullous diseases are associated with a high degree of morbidity and occasional mortality. Therapy of bullous diseases consists of suppressing the immune system, controlling infla...

Descripción completa

Detalles Bibliográficos
Autor principal: Mutasim, Diya F
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1936286/
https://www.ncbi.nlm.nih.gov/pubmed/18360613
_version_ 1782134371214426112
author Mutasim, Diya F
author_facet Mutasim, Diya F
author_sort Mutasim, Diya F
collection PubMed
description Autoimmune bullous diseases result from an immune response to molecular components of the desmosome or basement membrane. Bullous diseases are associated with a high degree of morbidity and occasional mortality. Therapy of bullous diseases consists of suppressing the immune system, controlling inflammation and improving healing of erosions. The therapeutic agents used in the treatment of bullous diseases may be associated with high morbidity and occasional mortality. Successful treatment requires understanding of the pathophysiology of the disease process and the pharmacology of the drugs being used.
format Text
id pubmed-1936286
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-19362862008-03-21 Therapy of autoimmune bullous diseases Mutasim, Diya F Ther Clin Risk Manag Review Autoimmune bullous diseases result from an immune response to molecular components of the desmosome or basement membrane. Bullous diseases are associated with a high degree of morbidity and occasional mortality. Therapy of bullous diseases consists of suppressing the immune system, controlling inflammation and improving healing of erosions. The therapeutic agents used in the treatment of bullous diseases may be associated with high morbidity and occasional mortality. Successful treatment requires understanding of the pathophysiology of the disease process and the pharmacology of the drugs being used. Dove Medical Press 2007-03 2007-03 /pmc/articles/PMC1936286/ /pubmed/18360613 Text en © 2007 Dove Medical Press Limited. All rights reserved
spellingShingle Review
Mutasim, Diya F
Therapy of autoimmune bullous diseases
title Therapy of autoimmune bullous diseases
title_full Therapy of autoimmune bullous diseases
title_fullStr Therapy of autoimmune bullous diseases
title_full_unstemmed Therapy of autoimmune bullous diseases
title_short Therapy of autoimmune bullous diseases
title_sort therapy of autoimmune bullous diseases
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1936286/
https://www.ncbi.nlm.nih.gov/pubmed/18360613
work_keys_str_mv AT mutasimdiyaf therapyofautoimmunebullousdiseases